Skip to main content
Erschienen in: Annals of Surgical Oncology 9/2020

25.03.2020 | Breast Oncology

Trends in Surgical Axillary Management in Early Stage Breast Cancer in Elderly Women: Continued Over-Treatment

verfasst von: Raphael J. Louie, MD MPH, Charles E. Gaber, MPH, Paula D. Strassle, PhD, Kristalyn K. Gallagher, DO, Stephanie M. Downs-Canner, MD, David W. Ollila, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 9/2020

Einloggen, um Zugang zu erhalten

Abstract

Introduction

In the past two decades, three prospective randomized trials demonstrated that elderly women with early stage hormone positive breast cancer had equivalent disease-specific mortality regardless of axillary surgery. In 2016, the Choosing Wisely campaign encouraged patients and providers to reconsider the role of axillary surgery in this population. We sought to identify factors that contribute to adopting non-operative management of the axilla in these patients.

Materials and Methods

We performed a retrospective analysis of women ≥ 70 years old with cT1/T2, hormone positive invasive ductal carcinoma who underwent partial or total mastectomy, with/without axillary surgery, and did not receive adjuvant chemotherapy from the National Cancer Database from 2004 to 2015. We used multivariable log-binomial regression to model the risk of undergoing axillary surgery across region, care setting, and Charlson–Deyo scores, and analyzed temporal trends using Poisson regression. From 2004 to 2015, 87,342 of 99,940 women who met inclusion criteria (83%) had axillary surgery. Over time, axillary surgery increased from 78% to 88% (p < 0.001). This rise was consistent across region (p = 0.81) and care setting (p = 0.09), but flattened as age increased (p < 0.001). Omitting axillary surgery was more likely in patients treated in New England (RR 0.88, 95% CI 0.86, 0.89) and patients ≥ 85 (RR 0.66, 95% CI 0.65, 0.67).

Conclusions

Axillary surgery continues to be the preferred option of axillary management in elderly women with early stage, clinically node negative, hormone-positive, invasive breast cancer despite no survival benefit. Identifying factors to improve patient selection and dissemination of current recommendations can improve adoption of current evidence on axillary surgery in the elderly.
Literatur
1.
Zurück zum Zitat Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569–75.CrossRef Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569–75.CrossRef
2.
Zurück zum Zitat Galimberti V, Cole BF, Zurrida S, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol. 2013;14(4):297–305.CrossRef Galimberti V, Cole BF, Zurrida S, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol. 2013;14(4):297–305.CrossRef
3.
Zurück zum Zitat Smith BD, Smith GL, Hurria A, et al. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol. 2009 ;27(17):2758–65CrossRef Smith BD, Smith GL, Hurria A, et al. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol. 2009 ;27(17):2758–65CrossRef
4.
Zurück zum Zitat Hughes KS, Schnaper LA, Berry D, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med. 2004;351(10):971–7.CrossRef Hughes KS, Schnaper LA, Berry D, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med. 2004;351(10):971–7.CrossRef
5.
Zurück zum Zitat Rudenstam CM, Zahrieh D, Forbes JF, et al. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93. J Clin Oncol. 2006;24(3):337–44.CrossRef Rudenstam CM, Zahrieh D, Forbes JF, et al. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93. J Clin Oncol. 2006;24(3):337–44.CrossRef
6.
Zurück zum Zitat Martelli G, Boracchi P, Ardoino I, et al. Axillary dissection versus no axillary dissection in older patients with T1N0 breast cancer: 15-year results of a randomized controlled trial. Ann Surg. 2012;256(6):920–4.CrossRef Martelli G, Boracchi P, Ardoino I, et al. Axillary dissection versus no axillary dissection in older patients with T1N0 breast cancer: 15-year results of a randomized controlled trial. Ann Surg. 2012;256(6):920–4.CrossRef
7.
Zurück zum Zitat Hughes KS, Schnaper LA, Bellon JR, et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol. 2013;31(19):2382–7.CrossRef Hughes KS, Schnaper LA, Bellon JR, et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol. 2013;31(19):2382–7.CrossRef
8.
Zurück zum Zitat Pesce C, Czechura T, Winchester DJ, et al. Axillary surgery among estrogen receptor positive women 70 years of age or older with clinical stage I breast cancer, 2004–2010: a report from the National Cancer Data Base. Ann Surg Oncol. 2013;20(10):3259–65.CrossRef Pesce C, Czechura T, Winchester DJ, et al. Axillary surgery among estrogen receptor positive women 70 years of age or older with clinical stage I breast cancer, 2004–2010: a report from the National Cancer Data Base. Ann Surg Oncol. 2013;20(10):3259–65.CrossRef
9.
Zurück zum Zitat Chagpar AB, Hatzis C, Pusztai L, et al. Association of lymph node evaluation with survival in women aged 70 years or older with clinically node-negative hormone receptor positive breast cancer. Ann Surg Oncol. 2017;24(10):3073–81.CrossRef Chagpar AB, Hatzis C, Pusztai L, et al. Association of lymph node evaluation with survival in women aged 70 years or older with clinically node-negative hormone receptor positive breast cancer. Ann Surg Oncol. 2017;24(10):3073–81.CrossRef
10.
Zurück zum Zitat Tamirisa N, Thomas SM, Fayanju OM, et al. Axillary nodal evaluation in elderly breast cancer patients: potential effects on treatment decisions and survival. Ann Surg Oncol. 2018;25(10):2890–98.CrossRef Tamirisa N, Thomas SM, Fayanju OM, et al. Axillary nodal evaluation in elderly breast cancer patients: potential effects on treatment decisions and survival. Ann Surg Oncol. 2018;25(10):2890–98.CrossRef
11.
Zurück zum Zitat Boughey JC, Haffty BG, Habermann EB, Hoskin TL, Goetz MP. Has the time come to stop surgical staging of the axilla for all women age 70 years or older with hormone receptor-positive breast cancer? Ann Surg Oncol. 2017;24(3):614–7.CrossRef Boughey JC, Haffty BG, Habermann EB, Hoskin TL, Goetz MP. Has the time come to stop surgical staging of the axilla for all women age 70 years or older with hormone receptor-positive breast cancer? Ann Surg Oncol. 2017;24(3):614–7.CrossRef
12.
Zurück zum Zitat Downs-Canner S, Zabor EC, Wind T, et al. Radiation therapy after breast-conserving surgery in women 70 years of age and older: how wisely do we choose? Ann Surg Oncol. 2019;26(4):969–75.CrossRef Downs-Canner S, Zabor EC, Wind T, et al. Radiation therapy after breast-conserving surgery in women 70 years of age and older: how wisely do we choose? Ann Surg Oncol. 2019;26(4):969–75.CrossRef
14.
Zurück zum Zitat Boffa DJ, Rosen JE, Mallin K, et al. Using the National Cancer Database for outcomes research: a review. JAMA Oncol. 2017;3(12):1722–8.CrossRef Boffa DJ, Rosen JE, Mallin K, et al. Using the National Cancer Database for outcomes research: a review. JAMA Oncol. 2017;3(12):1722–8.CrossRef
15.
Zurück zum Zitat Plichta JK, Thomas SM, Vernon R, et al. Breast cancer tumor histopathology, stage at presentation, and treatment in the extremes of age. Breast Cancer Res Treat. 2020;180:227–35.CrossRef Plichta JK, Thomas SM, Vernon R, et al. Breast cancer tumor histopathology, stage at presentation, and treatment in the extremes of age. Breast Cancer Res Treat. 2020;180:227–35.CrossRef
16.
Zurück zum Zitat Hanne Verbelen H, Gebruers N, Eeckhout F, et al. Shoulder and arm morbidity in sentinel node-negative breast cancer patients: a systematic review. Breast Cancer Res Treat. 2014;144:21–31.CrossRef Hanne Verbelen H, Gebruers N, Eeckhout F, et al. Shoulder and arm morbidity in sentinel node-negative breast cancer patients: a systematic review. Breast Cancer Res Treat. 2014;144:21–31.CrossRef
17.
Zurück zum Zitat Bello DM, Russell C, McCullough D, et al. Lymph node status in breast cancer does not predict tumor biology. Ann Surg Oncol. 2018;25(10):2884–9.CrossRef Bello DM, Russell C, McCullough D, et al. Lymph node status in breast cancer does not predict tumor biology. Ann Surg Oncol. 2018;25(10):2884–9.CrossRef
18.
Zurück zum Zitat Dominici LS, Sineshaw HM, Jemal A, et al. Patterns of axillary evaluation in older patients with breast cancer and associations with adjuvant therapy receipt. Breast Cancer Res Treat. 2018;167:555–66.CrossRef Dominici LS, Sineshaw HM, Jemal A, et al. Patterns of axillary evaluation in older patients with breast cancer and associations with adjuvant therapy receipt. Breast Cancer Res Treat. 2018;167:555–66.CrossRef
20.
Zurück zum Zitat Yao C, Boughey J. ‘Nudging’ surgeons and patients to de-escalation of surgery for breast cancer. Ann Surg Oncol. 2018;25:2777–80.CrossRef Yao C, Boughey J. ‘Nudging’ surgeons and patients to de-escalation of surgery for breast cancer. Ann Surg Oncol. 2018;25:2777–80.CrossRef
21.
Zurück zum Zitat In H, Bilimoria KY, Stewart AK, et al. Cancer recurrence: an important but missing variable in national cancer registries. Ann Surg Oncol. 2014;21: 1520–9.CrossRef In H, Bilimoria KY, Stewart AK, et al. Cancer recurrence: an important but missing variable in national cancer registries. Ann Surg Oncol. 2014;21: 1520–9.CrossRef
22.
Zurück zum Zitat Pezzi CM. Big data and clinical research in oncology: the good, the bad, the challenges and the opportunities. Ann Surg Oncol. 2014;21:1506–7.CrossRef Pezzi CM. Big data and clinical research in oncology: the good, the bad, the challenges and the opportunities. Ann Surg Oncol. 2014;21:1506–7.CrossRef
23.
Zurück zum Zitat Welsh JL, Hoskin TL, Day CN, et al. Predicting nodal positivity in women 70 years of age and older with hormone receptor-positive breast cancer to aid incorporation of a Society of Surgical Oncology Choosing Wisely guideline into clinical practice. Ann Surg Oncol. 2017;24(10):2881–8.CrossRef Welsh JL, Hoskin TL, Day CN, et al. Predicting nodal positivity in women 70 years of age and older with hormone receptor-positive breast cancer to aid incorporation of a Society of Surgical Oncology Choosing Wisely guideline into clinical practice. Ann Surg Oncol. 2017;24(10):2881–8.CrossRef
24.
Zurück zum Zitat Ross DT, Perou CM. A comparison of gene expression signatures from breast tumors and breast tissue derived cell lines. Dis Markers. 2001;17(2):99–109CrossRef Ross DT, Perou CM. A comparison of gene expression signatures from breast tumors and breast tissue derived cell lines. Dis Markers. 2001;17(2):99–109CrossRef
Metadaten
Titel
Trends in Surgical Axillary Management in Early Stage Breast Cancer in Elderly Women: Continued Over-Treatment
verfasst von
Raphael J. Louie, MD MPH
Charles E. Gaber, MPH
Paula D. Strassle, PhD
Kristalyn K. Gallagher, DO
Stephanie M. Downs-Canner, MD
David W. Ollila, MD
Publikationsdatum
25.03.2020
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 9/2020
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-020-08388-8

Weitere Artikel der Ausgabe 9/2020

Annals of Surgical Oncology 9/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.